| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Aug―22 |
Phylogenetic insights into SARS-CoV-2 introductions and spread in Georgia |
G. Veytsel, L. Lyu, G. Stott, L. R. Carmola, H. Dishman, J. Bahl |
| 2 |
[GO] |
2026―Aug―07 |
Newcastle disease virus is a safe and immunogenic respiratory-delivered vaccine against SARS-CoV-2 in a ferret model |
Sara Pagliarani, Jaime Tuling, Phuc H. Pham, Alexander Leacy, Igor R. Santos, Praveen Akmeemana, Melanie M. Goens, Pauline Delnatte, Brandon N. Lillie, Jamie Sookhoo, Andrea Kroeker, Shawn Babiuk, Darryl Falzarano, Sarah K. Wootton, Leonardo Susta |
| 3 |
[GO] |
2026―Jul―22 |
Genome-wide screening identifies unique host-directed drugs and pro-viral signalling pathways for SARS-CoV-2 |
Juveriya Qamar Khan, Karthic Rajamanickam, Frederick S. Vizeacoumar, Mahrokh Balouchi, Yue Zhang, Hussain Elhasasna, Megha Rohamare, He Dong, Kathleen Glover, Tristan Anderson-Woodsworth, Kalpana K. Bhanumathy, Jocelyne Lew, Franco J. Vizeacoumar, Darryl Falzarano, Anil Kumar, Joyce A. Wilson |
| 4 |
[GO] |
2026―Mar―19 |
SARS-CoV-2 crossreactive B-cells outnumber seasonal coronavirus spike-specific clones at the end of the COVID-19 pandemic |
Cristina Gonzalez-Lopez, Muriel Aguilar-Bretones, Julian Reinders, Jingshu Zhang, Petra van den Doel, Batuhan Bekki, Eric C. van Gorp, P. Hugo M. van der Kuy, Bart L. Haagmans, Corine H. GeurtsVanKessel, Marion P. G. Koopmans, Rory D. de Vries, Marit J. van Gils, Gijsbert P. van Nierop |
| 5 |
[GO] |
2026―Mar―13 |
Ordinary differential equation models of SARS-CoV-2 replication dynamics and antiviral drug efficacies |
Timon Kapischke, Simon T. Herrmann, Luca D. Bertzbach, Stephanie Pfaender, Lars Kaderali |
| 6 |
[GO] |
2026―Mar―02 |
Prolonged dysregulation and pathological changes in the upper respiratory tract of SARS-CoV-2 infected hamsters |
Feifei Liu, Yao Xia, Andrew Chak-Yiu Lee, Yanxia Chen, Zhe Chen, Yixin He, Celia Hoi-Ching Chan, Jianpiao Cai, Terrence Tsz-Tai Yuen, Zi-Wei Ye, Jinxia Zhang, Zhaohui Qian, Kwok-Yung Yuen, Jasper Fuk-Woo Chan, Hin Chu |
| 7 |
[GO] |
2026―Feb―27 |
COVID-19 boosters restore virus-specific immune responses in kidney transplant recipients unresponsive to primary vaccination |
Yvette den Hartog, Yannick van Sleen, Lennert Gommers, Luca M. Zaeck, Daryl Geers, A. Lianne Messchendorp, Jan-Stephan F. Sanders, Carla C. Baan, Debbie van Baarle, Rory D. de Vries, Aiko P. J. de Vries, Alfonso Abrahams, Marc H. Hemmelder, Dimitri Diavatopoulos, Luuk H. J. Hilbrands, Frederiek J. Bemelman, Esther Remmerswaal, Ron T. Gansevoort, Jan Stephan F. Sanders, Debbie van Baarle, Marcia M. Kho, Marlies E. J. Reinders, Rory D. de Vries, Renate van der Molen |
| 8 |
[GO] |
2026―Feb―26 |
Inequities and global declines in SARS-CoV-2 genomic data availability hinder response to emerging variants |
Emily A. Smith, Derek F. Fleming, Eve M. Lackritz, Angela K. Ulrich |
| 9 |
[GO] |
2026―Jan―09 |
K5 polysaccharides inhibit SARS-CoV-2 infection by preventing spike-proteolytic priming |
Maria Milanesi, Chiara Urbinati, Liv Zimmermann, Pasqua Oreste, Alberto Zani, Arnaldo Caruso, Francesca Caccuri, Vibor Laketa, Petr Chlanda, Rebecca C. Wade, Marco Rusnati, Giulia Paiardi |
| 10 |
[GO] |
2025―Oct―29 |
Estimating the decay of protective antibodies induced by SARS-CoV-2 mRNA vaccination and hybrid immunity |
McKenna D. Roe, Si’Ana A. Coggins, Emily S. Darcey, Emilie Goguet, Hannah Haines-Hull, Dominic Esposito, Cara H. Olsen, Simon D. Pollett, Edward Mitre, Eric D. Laing |
| 11 |
[GO] |
2025―Oct―24 |
Gut infection and dysbiosis are hallmarks of severe SARS-CoV-2 variants |
Santhosh K. Nagaraj, Christy M. Joy, Rishad Shiraz, Rohan Narayan, Sumandeep Kaur, Oyahida Khatun, Sagar Dubey, James Ng, Nischay Mishra, Shashank Tripathi |
| 12 |
[GO] |
2025―Sep―02 |
Distinct circulating autoantibodies are associated with COVID-19 hospitalization and SARS-CoV-2 neutralization activity |
Rajesh Abraham Jacob, Hannah O. Ajoge, Michael R. D’Agostino, Altynay Shigayeva, Arinjay Banerjee, Matthew S. Miller, Allison J. McGeer, Samira Mubareka, Karen Mossman |
| 13 |
[GO] |
2025―Aug―19 |
Genomic surveillance in Morocco tracks SARS-CoV-2 variant shift from Alpha to Omicron sublineage JN1 |
Oumaima Bouddahab, Safaa Aqillouch, Hicham Charoute, Rachid Noureddine, Adil El Hamouchi, Oumaima Laazaazia, Achraf Aainouss, Hanâ Baba, Ahd Ouladlahsen, Pascal Pineau, M’hammed Sarih, Abderrahmane Maaroufi, Mustapha Lkhider, Abdelhamid Barakat, Sayeh Ezzikouri |
| 14 |
[GO] |
2025―Aug―18 |
Survival and transmission fitness of SARS-CoV-2 over the time-of-flight in an aerosolization chamber |
Yiying Zhang, Justin M. Donovan, Dylan W. Weninger, Victor Lam, Richard Gibson, Steven Renaud, Daniel Paquette, Alex Lescanec, Cody Hird, Christopher T. DeGroot, Jessica L. Prodger, Franco Berruti, Eric Savory, Eric J. Arts |
| 15 |
[GO] |
2025―Jul―29 |
Merbecovirus S2 subunit vaccines elicit cross reactive antibodies and provide partial protection against MERS coronavirus |
Peter J. Halfmann, Jeong Soo Lee, Augustine Duffy, Bingcheng Huang, Jie E. Yang, Elizabeth R. Wright, Yoshihiro Kawaoka, Ravi S. Kane |
| 16 |
[GO] |
2025―Jun―20 |
Longitudinal kinetics of the viral infection biomarker 3′-deoxy-3′,4′-didehydro-cytidine in SARS-CoV-2, influenza A virus and RSV human challenge models |
Ravi Mehta, Elena Chekmeneva, Stephanie Ascough, Helen Wagstaffe, Loukas Papargyris, Malick Gibani, Ada H. Y. Yuen, Maria Valdivia-Garcia, Caroline Sands, María Gómez-Romero, Ewurabena A. Mills, Vincenzo Sgro, Lydia Slater, Pete Dayananda, Claire Broderick, Jiayun Xu, Myrsini Kaforou, Lynn Maslen, Mahdad Noursadeghi, Andrew J. Pollard, Wendy Barclay, Zoltan Takats, Christopher Chiu, Shiranee Sriskandan |
| 17 |
[GO] |
2025―Jun―04 |
Differential patterns of cross-protection against antigenically distinct variants in small animal models of SARS-CoV-2 infection |
Prabhuanand Selvaraj, Charles B. Stauft, Shufeng Liu, Kotou Sangare, Tony T. Wang |
| 18 |
[GO] |
2025―May―01 |
SARS-CoV-2 variants retain high airborne transmissibility by different strategies |
Jie Zhou, Ksenia Sukhova, Rebecca Frise, Laury Baillon, Jonathan C. Brown, Thomas P. Peacock, Wilhelm Furnon, Vanessa M. Cowton, Arvind H. Patel, Massimo Palmarini, Wendy S. Barclay |
| 19 |
[GO] |
2025―Apr―25 |
Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus |
Wen Shi Lee, George Taiaroa, Robyn Esterbauer, Meghan Conlan, Jessica A. Neil, Matthew J. Gartner, Monique Smith, Mingyang Wang, Rory A. Shepherd, Thomas Tran, Phillip Pymm, Lara S. U. Schwab, Andrew Kelly, Ellie Reilly, Thakshila Amarasena, Bruce D. Wines, P. Mark Hogarth, Jennifer A. Juno, Stephen J. Kent, Hyon-Xhi Tan, Kanta Subbarao, Adam K. Wheatley |
| 20 |
[GO] |
2025―Apr―01 |
Balancing stability and function: impact of the surface charge of SARS-CoV-2 Omicron spike protein |
Daniel Lauster, Rainer Haag, Matthias Ballauff, Andreas Herrmann |
| 21 |
[GO] |
2025―Mar―13 |
Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant |
Peter J. Halfmann, Jeong Soo Lee, Nikki McArthur, Ojas Gupta, Yoshihiro Kawaoka, Ravi S. Kane |
| 22 |
[GO] |
2025―Feb―24 |
Pathogenesis and transmission of SARS-CoV-2 D614G, Alpha, Gamma, Delta, and Omicron variants in golden hamsters |
Andra Banete, Bryan D. Griffin, Juan C. Corredor, Emily Chien, Lily Yip, Tarini N. A. Gunawardena, Kuganya Nirmalarajah, Jady Liang, Yaejin Lee, Alexander Leacy, Sara Pagliarani, Richard de Borja, Winfield Yim, Hunsang Lee, Yu Onodera, Patryk Aftanas, Patrick Budylowski, Sang Kyun Ahn, Yanlong Pei, Hong Ouyang, Laura Kent, Xinliu Angel Li, Mario A. Ostrowski, Robert A. Kozak, Sarah K. Wootton, Natasha Christie-Holmes, Scott D. Gray-Owen, Mikko Taipale, Jared T. Simpson, Finlay Maguire, Allison J. McGeer, Haibo Zhang, Leonardo Susta, Theo J. Moraes, Samira Mubareka |
| 23 |
[GO] |
2025―Feb―03 |
An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters |
Ryuta Uraki, Mutsumi Ito, Maki Kiso, Kiyoko Iwatsuki-Horimoto, Masafumi Endo, Seiya Yamayoshi, Yoshihiro Kawaoka |
| 24 |
[GO] |
2024―Dec―30 |
Middle East respiratory syndrome coronavirus (MERS-CoV) internalization does not rely on DPP4 cytoplasmic tail signaling |
Karthika Thankamani, Divakar Shubham, Gayatri Kandpal, Ann Mary Isaac, Modenkattil Sethumadhavan Kavitha, V. Stalin Raj |
| 25 |
[GO] |
2024―Dec―30 |
Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assay |
Danielle W. Ali, Maggie L. Bartlett, Christopher D. Heger, Francisco Ramirez, Linwood Johnson, Kevin L. Schully, Eric D. Laing, Wei Wang, Carol D. Weiss, Emilie Goguet, Christopher C. Broder, Stephanie A. Richard, Nusrat J. Epsi, Brian Agan, David Tribble, Mark P. Simons, Timothy H. Burgess, Edward Mitre, Simon Pollett, Darci R. Smith |
| 26 |
[GO] |
2024―Dec―17 |
A portrait of the infected cell: how SARS-CoV-2 infection reshapes cellular processes and pathways |
Valentina Marano, Štěpánka Vlachová, Sofia Maria Luigia Tiano, Mirko Cortese |
| 27 |
[GO] |
2024―Nov―21 |
Reduced cross-protective potential of Omicron compared to ancestral SARS-CoV-2 spike vaccines against potentially zoonotic coronaviruses |
Tyler M. Renner, Matthew Stuible, Brian Cass, Sylvie Perret, Julie Guimond, Simon Lord-Dufour, Michael J. McCluskie, Yves Durocher, Bassel Akache |
| 28 |
[GO] |
2024―Nov―21 |
Sensitivity of rodents to SARS-CoV-2: Gerbils are susceptible to SARS-CoV-2, but guinea pigs are not |
Kiyoko Iwatsuki-Horimoto, Maki Kiso, Mutsumi Ito, Seiya Yamayoshi, Yoshihiro Kawaoka |
| 29 |
[GO] |
2024―Nov―14 |
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants |
Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana Chang, Ahmed Mostafa, Madhubanti Basu, Sanghita Sarkar, Simran Panjwani, Yaelyn H. Ha, Yao Ma, Chengjin Ye, Qian Wang, Todd J. Green, James L. Kizziah, Nathaniel B. Erdmann, Paul A. Goepfert, Lihong Liu, David D. Ho, Luis Martinez-Sobrido, Mark R. Walter, James J. Kobie |
| 30 |
[GO] |
2024―Nov―05 |
Characterization of a SARS-CoV-2 Omicron BA.5 direct-contact transmission model in hamsters |
Kim Handrejk, Katharina S. Schmitz, Edwin J. B. Veldhuis Kroeze, Laura L. A. van Dijk, Peter van Run, Bart Haagmans, Anne Moscona, Matteo Porotto, Rik L. de Swart, Rory D. de Vries, Melanie Rissmann |
| 31 |
[GO] |
2024―Oct―17 |
Discordant phylodynamic and spatiotemporal transmission patterns driving the long-term persistence and evolution of human coronaviruses |
Marcus G. Mah, Michael A. Zeller, Rong Zhang, Yan Zhuang, Venance P. Maro, John A. Crump, Matthew P. Rubach, Eng Eong Ooi, Jenny G. Low, De Yun Wang, Gavin J. D. Smith, Yvonne C. F. Su |
| 32 |
[GO] |
2024―Sep―02 |
Resistance to SARS-CoV-2 infection in camelid nasal organoids is associated with lack of ACE2 expression |
Tim I. Breugem, Samra Riesebosch, Debby Schipper, Anna Z. Mykytyn, Petra van den Doel, Joaquim Segalés, Mart M. Lamers, Bart L. Haagmans |
| 33 |
[GO] |
2024―Aug―24 |
SARS-CoV-2 infection results in a unique lung proteome long after virus resolution in the hamster |
Amrit S. Boese, Bryce M. Warner, Peter McQueen, Robert Vendramelli, Nikesh Tailor, Bryan D. Griffin, Mable Chan, Jonathan Audet, Anders Leung, Stuart McCorrister, Chris Grant, Garrett Westmacott, Darwyn Kobasa |
| 34 |
[GO] |
2024―Aug―23 |
Beyond COVID-19: the promise of next-generation coronavirus vaccines |
Reshma Koolaparambil Mukesh, Claude K. Yinda, Vincent J. Munster, Neeltje van Doremalen |
| 35 |
[GO] |
2024―Aug―22 |
Transmission dynamics of MERS-CoV in a transgenic human DPP4 mouse model |
Neeltje van Doremalen, Trenton Bushmaker, Robert J. Fischer, Atsushi Okumura, Dania M. Figueroa Acosta, Rebekah J. McMinn, Michael Letko, Dana Scott, Greg Saturday, Vincent J. Munster |
| 36 |
[GO] |
2024―Aug―06 |
Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1 |
Stephanie K. Lathrop, Jordan J. Clark, Karthik Siram, Robert Andreata-Santos, Jeremy Yong, Rebekah D. Tee, Clara J. Davison, Gagandeep Singh, David Burkhart, Florian Krammer, Jay T. Evans |
| 37 |
[GO] |
2024―Jul―16 |
Jamaican fruit bat (Artibeus jamaicensis) insusceptibility to mucosal inoculation with SARS-CoV-2 Delta variant is not caused by receptor compatibility |
Julia R. Port, Jade C. Riopelle, Sarah van Tol, Arthur Wickenhagen, Eric Bohrnsen, Daniel E. Sturdevant, Rebecca Rosenke, Jamie Lovaglio, Justin Lack, Sarah L. Anzick, Kathleen Cordova, Kwe Claude Yinda, Patrick W. Hanley, Tony Schountz, Lon V. Kendall, Carl I. Shaia, Greg Saturday, Craig Martens, Benjamin Schwarz, Vincent J. Munster |
| 38 |
[GO] |
2024―Jul―09 |
Evolution at Spike protein position 519 in SARS-CoV-2 facilitated adaptation to humans |
C. Cereghino, K. Michalak, S. DiGiuseppe, J. Guerra, D. Yu, A. Faraji, A. K. Sharp, A. M. Brown, L. Kang, J. Weger-Lucarelli, P. Michalak |
| 39 |
[GO] |
2024―Jun―24 |
Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir |
Laura Krismer, Helge Schöppe, Stefanie Rauch, David Bante, Bernhard Sprenger, Andreas Naschberger, Francesco Costacurta, Anna Fürst, Anna Sauerwein, Bernhard Rupp, Teresa Kaserer, Dorothee von Laer, Emmanuel Heilmann |
| 40 |
[GO] |
2024―Jun―03 |
Tracing household transmission of SARS-CoV-2 in New Zealand using genomics |
Lauren Jelley, Nayyereh Aminisani, Meaghan O’Neill, Tineke Jennings, Jordan Douglas, Srushti Utekar, Helen Johnston, David Welch, James Hadfield, Nikki Turner, Tony Dowell, Annette Nesdale, Hazel C. Dobinson, Priscilla Campbell-Stokes, Michelle Balm, Cameron C. Grant, Karen Daniells, Peter McIntyre, Adrian Trenholme, Cass Byrnes, Ruth Seeds, Tim Wood, Megan Rensburg, Jort Cueto, Ernest Caballero, Joshma John, Emmanuel Penghulan, Danielle Currin, Mary Ryan, Andrea Bowers, Chor Ee Tan, Judy Bocacao, Wendy Gunn, Bryden Bird, Tegan Slater, Farjana Ahmed, Mai Anh Sam, Elaisa Glampe, Gabriella Davey, Joep de Ligt, David Winter, Nigel French, Paul G. Thomas, Richard J. Webby, Sue Huang, Jemma L. Geoghegan |
| 41 |
[GO] |
2024―Feb―21 |
The Wnt/β-catenin pathway is important for replication of SARS-CoV-2 and other pathogenic RNA viruses |
Zaikun Xu, Mohamed Elaish, Cheung Pang Wong, Bardes B. Hassan, Joaquin Lopez-Orozco, Alberto Felix-Lopez, Natacha S. Ogando, Les Nagata, Lara K. Mahal, Anil Kumar, Joyce A. Wilson, Ryan Noyce, Irv Mayers, Christopher Power, David Evans, Tom C. Hobman |
| 42 |
[GO] |
2024―Feb―14 |
Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients |
Yvette den Hartog, S. Reshwan K. Malahe, Wim J. R. Rietdijk, Marjolein Dieterich, Lennert Gommers, Debbie van Baarle, Dimitri A. Diavatopoulos, A. Lianne Messchendorp, Renate G. van der Molen, Ester B. M. Remmerswaal, Frederike J. Bemelman, Marcia M. L. Kho, Corine H. GeurtsvanKessel, Marion P. G. Koopmans, Ron T. Gansevoort, Luuk B. Hilbrands, Jan-Stephan Sanders, Marlies E. J. Reinders, Carla C. Baan, Rory D. de Vries, Alferso C. Abrahams, Marije C. Baas, Pim Bouwmans, Marc H. Hemmelder, Marc A. G. J. ten Dam, Sophie C. Frölke, Dorien Standaar, Marieke van der Heiden, Celine Imhof, Priya Vart, Yvonne M. R. Adema, Marieken J. Boer-Verschragen, Wouter B. Mattheussens, Ria Philipsen, Djenolan van Mourik, Nynke Rots, Gerco den Hartog, Rob van Binnendijk |
| 43 |
[GO] |
2024―Jan―09 |
Airborne transmission efficiency of SARS-CoV-2 in Syrian hamsters is not influenced by environmental conditions |
Claude Kwe Yinda, Julia R. Port, Trenton Bushmaker, Jonathan E. Schulz, Shane Gallogly, Robert J. Fischer, Vincent J. Munster |
| 44 |
[GO] |
2023―Dec―13 |
Singapore COVID-19 data cross-validation by the Gaidai reliability method |
Oleg Gaidai, Vladimir Yakimov, Jiayao Sun, Eric-Jan van Loon |
| 45 |
[GO] |
2023―Dec―13 |
Survey of white-footed mice (Peromyscus leucopus) in Connecticut, USA reveals low SARS-CoV-2 seroprevalence and infection with divergent betacoronaviruses |
Rebecca Earnest, Anne M. Hahn, Nicole M. Feriancek, Matthew Brandt, Renata B. Filler, Zhe Zhao, Mallery I. Breban, Chantal B. F. Vogels, Nicholas F. G. Chen, Robert T. Koch, Abbey J. Porzucek, Afeez Sodeinde, Alexa Garbiel, Claire Keanna, Hannah Litwak, Heidi R. Stuber, Jamie L. Cantoni, Virginia E. Pitzer, Ximena A. Olarte Castillo, Laura B. Goodman, Craig B. Wilen, Megan A. Linske, Scott C. Williams, Nathan D. Grubaugh |
| 46 |
[GO] |
2023―Dec―05 |
Rural populations facilitated early SARS-CoV-2 evolution and transmission in Missouri, USA |
Cynthia Y. Tang, Tao Li, Tricia A. Haynes, Jane A. McElroy, Detlef Ritter, Richard D. Hammer, Christopher Sampson, Richard Webby, Jun Hang, Xiu-Feng Wan |
| 47 |
[GO] |
2023―Nov―14 |
Evolutionary trajectory of SARS-CoV-2 genome shifts during widespread vaccination and emergence of Omicron variant |
Kaitlyn Gayvert, Sheldon McKay, Wei Keat Lim, Alina Baum, Christos Kyratsous, Richard Copin, Gurinder S. Atwal |
| 48 |
[GO] |
2023―Oct―18 |
Novel mechanism of the COVID-19 associated coagulopathy (CAC) and vascular thromboembolism |
Mahavir Singh, Sathnur Pushpakumar, Yuting Zheng, Irina Smolenkova, Oluwaseun E. Akinterinwa, Bana Luulay, Suresh C. Tyagi |
|
